Post-treatment Visual Acuity Prediction Using Deep Learning in Age-related Macular Degeneration

被引:0
|
作者
Kim, Najung [1 ]
Kim, Hyung Chan [1 ]
Chung, Hyewon [1 ]
Lee, Hyungwoo [1 ,2 ]
机构
[1] Konkuk Univ, Med Ctr, Sch Med, Dept Ophthalmol, Seoul, South Korea
[2] Konkuk Univ, Med Ctr, Dept Ophthalmol, 120-1 Neungdong Ro, Seoul 05030, South Korea
来源
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY | 2023年 / 64卷 / 07期
基金
新加坡国家研究基金会;
关键词
Age-related macular degeneration; Deep learning; Prediction; Visual acuity; RISK-FACTORS; RANIBIZUMAB; PREVALENCE; OUTCOMES; THERAPY;
D O I
10.3341/jkos.2023.64.7.582
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To develop a deep learning model to predict visual acuity (VA) outcomes after 12 months of anti-vascular endothelial growth factor (anti-VEGF) treatment.Methods: A total of 330 treatment-naive eyes of neovascular age-related macular degeneration patients, who underwent anti-VEGF therapy between 2007 and 2020 at Konkuk University medical center, were included. The network was trained using VA at baseline, VA after three loading doses of anti-VEGF, and treatment regimen data. It was also trained using 12,300 augmented optical coherence tomography (OCT) B-scan images at baseline and after three loading doses of anti-VEGF. We generated five deep learning models using sequentially input data (VA and OCT B-scan images at baseline and after three loading doses, and treatment regimen). Prediction of VA at 12 months was performed using deep learning algorithms, such as convolutional neural network and multilayer perceptron. The outcomes were dichotomized based on whether the decremental change in VA during the 12 months of treatment was more or less than logarithm of the minimum angle of resolution 0.3. Predictive efficiency was assessed by comparing the performance of deep learning models.Results: The best performing model was trained using input data, including VA at baseline and after three loading doses, treatment regimen, and OCT B-scan images at baseline and after three loading doses. The decremental outcome in VA after 12 months of anti-VEGF treatment was predicted as an area under the curve (AUC) of 0.79. The addition of OCT images at baseline and after three loading doses as input data improved the AUC, sensitivity, and negative predictive value (AUC 0.74-0.79, 0.58-0.86, and 0.90-0.95, respectively). Conclusions: Our deep learning model showed relatively good performance in classifying good or poor post-treatment VA based on combined clinical information including numerical and image data. J Korean Ophthalmol Soc 2023;64(7):582-590
引用
收藏
页码:582 / 590
页数:9
相关论文
共 50 条
  • [41] Relationship between foveal birefringence and visual acuity in neovascular age-related macular degeneration
    Weber, A.
    Elsner, A. E.
    Miura, M.
    Kompa, S.
    Cheney, M. C.
    EYE, 2007, 21 (03) : 353 - 361
  • [42] Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials
    Jaffe, Glenn J.
    Ying, Gui-Shuang
    Toth, Cynthia A.
    Daniel, Ebenezer
    Grunwald, Juan E.
    Martin, Daniel F.
    Maguire, Maureen G.
    OPHTHALMOLOGY, 2019, 126 (02) : 252 - 260
  • [43] Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy
    Hashimoto, Yohei
    Hunt, Adrian Robert
    Wells, Jane M.
    Banerjee, Gayatri
    Ferrier, Ross
    Barry, Richard
    Field, Andrew
    Game, Justin
    Hooper, Claire Yvonne
    Barthelmes, Daniel
    Gillies, Mark C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024,
  • [44] Preserving visual acuity: a compelling 12-year case study of controlling neovascular age-related macular degeneration
    Tomas, Rita
    Campos, Antonio
    Oliveira, Nuno
    Soares, Pedro
    Sousa, Joao
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [45] Predicting Visual Acuity From Visual Field Sensitivity in Age-Related Macular Degeneration
    Denniss, Jonathan
    Baggaley, Helen C.
    Astle, Andrew T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (11) : 4590 - 4597
  • [46] TREATMENT OF AGE-RELATED MACULAR DEGENERATION
    Real Juan, Pablo
    Tartara, Ignacio
    Allemandi, Daniel
    Granero, Gladys
    Palma Santiago, Daniel
    ATENCION FARMACEUTICA, 2011, 13 (03): : 160 - 171
  • [47] Age-related macular degeneration
    Jee, Donghyun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (08): : 500 - 505
  • [48] Visual Acuity Outcomes in Patients Receiving Frequent Treatment of Neovascular Age-Related Macular Degeneration in Clinical Practice
    Moshfeghi, Andrew A.
    Pitcher, John D.
    Lucas, Genevieve
    Boucher, Nick
    Saroj, Namrata
    JOURNAL OF VITREORETINAL DISEASES, 2021, 5 (03) : 221 - 226
  • [49] Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration
    Hirami, Yasuhiko
    Mandai, Michiko
    Takahashi, Masayo
    Teramukai, Satoshi
    Tada, Harue
    Yoshimura, Nagahisa
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (04) : 396 - 407
  • [50] Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials
    Kenji Yamashiro
    Akio Oishi
    Masayuki Hata
    Ayako Takahashi
    Akitaka Tsujikawa
    Japanese Journal of Ophthalmology, 2021, 65 : 741 - 760